Can blocking a DNA repair protein make immunotherapy work better against colorectal cancer?

NCT ID NCT07811193

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 17, 2026 · Updated 3 times

Summary

Researchers are testing a new drug, VVD-133214, combined with pembrolizumab in people with advanced colorectal cancer that has MSI and/or dMMR. These tumors rely on a protein called Werner helicase to survive, and VVD-133214 is designed to block it. The trial compares the combination to pembrolizumab alone to see if it improves progression-free survival and to find the best dose. Participants have not received prior treatment for advanced disease and will receive the combination for as long as it helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
VVD-133214, an experimental drug that blocks the Werner helicase protein, given with pembrolizumab
What this could lead to
If the combination works, it could offer a new first-line option for advanced colorectal cancer with MSI and/or dMMR, a group that needs better treatments.
What could go wrong
This is a phase 2 trial, so it may not show a clear benefit over pembrolizumab alone. Blocking Werner helicase could cause side effects, and the combination may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Eastern Cooperative Oncology Group (ECOG) performance-status score of 0 or 1 * Have a known microsatellite instability (MSI) and/or deficient mismatch repair (dMMR) tumor status confirmed per local standard of care (SoC), and have histologically or cytologically documented advanced (unresectable and/or metastatic) colorectal adenocarcinoma (CRC) * No prior systemic treatment for metastatic disease and not amenable to curative resection * Participants must have documented MSI and/or dMMR tumor status determined as part of the routine diagnostic workup in a certified laboratory * Availability of formaldehyde-fixed paraffin-embedded (FFPE) archival tumor tissue for submission to Sponsor/central laboratory for retrospective central testing including a copy of a redacted pathology report if available * Presence of measurable disease according to RECIST v1.1 * Adequate hematologic and end-organ function, defined using laboratory results obtained within 14 days prior to first dose of study treatment * Females of childbearing potential must have negative serum pregnancy test before starting study treatment Exclusion Criteria: * Prior systemic treatment for advanced CRC. Participants may have received prior adjuvant chemotherapy as long as disease progression occurred at least 12 months after the last dose of adjuvant treatment * Prior treatment with adjuvant immunotherapy (e.g., anti-PD-1, anti-PD-L1, anti-PD-L2 agent, or anti-CTLA-4 agent, or any other antibody or drug specifically targeting T cell co-stimulation or immune checkpoint pathways, including prior therapy with anti-tumor vaccines or other immuno-stimulatory antitumor agents, etc.) * Known active or uncontrolled central nervous system (CNS) or brain metastases (progressing or requiring anticonvulsants or corticosteroids for symptomatic control) and/or carcinomatous meningitis * Patients with active or history of autoimmune disease or immune deficiency that has required treatment in past 2 years * History of malignancy other than CRC, within 5 years prior to screening. Participants with Lynch syndrome are not excluded. * Participants requiring treatment with systemic immunosuppressive medication (such as corticosteroids) within 2 weeks prior to initiation of study treatment, or anticipation of need for systemic immunosuppressive medication during study treatment * Participants with active hepatitis B, hepatitis C or HIV * Participants with known Werner Syndrome (WRN) * Prior treatment with any WRN helicase inhibitor

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal adenocarcinoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal adenocarcinoma Colorectal Neoplasms, Hereditary Nonpolyposis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    121 sites in 21 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A.O.U. Universita' Degli Studi Della Campania Luigi Vanvitelli - Oncoematologia

    NOT_YET_RECRUITING

    Naples, 80131, Italy

  • ASST Grande Ospedale Metropolitano Niguarda - Oncologia Falck

    NOT_YET_RECRUITING

    Milan, Milan, 20162, Italy

  • AZ Delta - Digestive oncology

    NOT_YET_RECRUITING

    Roeselare, 8800, Belgium

  • Ankara Bilkent Sehir Hastanesi

    NOT_YET_RECRUITING

    Bilkent Çankaya, Ankara, 6800, Turkey (Türkiye)

  • Ankara Etlik Sehir Hastanesi

    NOT_YET_RECRUITING

    Yenimahalle, 6170, Turkey (Türkiye)

  • Asan Medical Center | Oncology

    NOT_YET_RECRUITING

    Seoul, Seoul, 05505, South Korea

  • Asklepios Klinik Altona - Onkologie, Hämatologie, Palliativmedizin, Rheumatologie und Pneumologie

    NOT_YET_RECRUITING

    Hamburg, Free and Hanseatic City of Hamburg, 22763, Germany

  • Athens Medical Center S.A./ European Interbalkan Medical Center - 4th Department of Medical Oncology

    NOT_YET_RECRUITING

    Pylaia, Thessaloniki, 570 01, Greece

  • Beijing Cancer Hospital - Oncology Department

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100142, China

  • Białostockie Centrum Onkologii im. M. Skłodowskiej-Curie w Białymstoku Oddział Onkologii Klinicznej

    NOT_YET_RECRUITING

    Bialystok, 15-027, Poland

  • Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit

    NOT_YET_RECRUITING

    Detroit, Michigan, 48202, United States

  • CHRU de Besancon - Hopital Jean Minjoz - Medical Oncology

    NOT_YET_RECRUITING

    Besançon, 25030, France

  • CHU Brest - Hopital La Cavale Blanche - service oncologie medicale

    NOT_YET_RECRUITING

    Brest, Brittany Region, 29200, France

  • CHU Helora - Hopital de La Louvière - Site Jolimont - Oncology department

    NOT_YET_RECRUITING

    La Louvière, Hainaut, 7100, Belgium

  • Cengild G.I. Medical Centre - Curie Oncology KL

    NOT_YET_RECRUITING

    Kuala Lumpur, 59200, Malaysia

  • Centro Medico Fleischer

    NOT_YET_RECRUITING

    Buenos Aires, Buenos Aires, C1414, Argentina

  • Centrum Medyczne Pratia Poznan

    NOT_YET_RECRUITING

    Skorzewo, 60-185, Poland

  • Chang Gung Memorial Hospital Kaohsiung

    NOT_YET_RECRUITING

    Kaohsiung City, Kaohsiung, 803, Taiwan

  • Chang Gung Memorial Hospital at Linkou

    NOT_YET_RECRUITING

    Taipei, Taipei, 10507, Taiwan

  • Chi Mei Medical Center, Yongkang Branch

    NOT_YET_RECRUITING

    Tainan, 71004, Taiwan

  • Comarch Healthcare SA Centrum Medyczne iMed24

    NOT_YET_RECRUITING

    Krakow, 31-864, Poland

  • Complexo Hospitalario Universitario De Santiago | Oncologia

    NOT_YET_RECRUITING

    Santiago de Compostela, A Coruña, 15706, Spain

  • Curie Oncology | Farrer

    NOT_YET_RECRUITING

    Singapore, 329563, Singapore

  • DRK Kliniken Berlin-Köpenick - Darmzentrum

    NOT_YET_RECRUITING

    Berlin, State of Berlin, 12559, Germany

  • Europejskie Centrum Zdrowia Otwock, Szpital im. F. Chopina

    NOT_YET_RECRUITING

    Otwock, 05-400, Poland

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica

    NOT_YET_RECRUITING

    Roma, 00168, Italy

  • Fujian Cancer Hospital

    NOT_YET_RECRUITING

    Fuzhou, Fujian, 350014, China

  • Fundacao Pio XII - Hospital de Cancer de Barretos

    NOT_YET_RECRUITING

    Jaú, São Paulo, 14784-400, Brazil

  • Fundación Intecnus

    NOT_YET_RECRUITING

    Bariloche, Río Negro Province, RP82 8400, Argentina

  • Gaziantep Sehir Hastanesi -Medical Oncology Department

    NOT_YET_RECRUITING

    Gaziantep, 27470, Turkey (Türkiye)

  • General Hospital Of Athens Alexandra-Plasma Cell Dyscrasias Unit, Department of Clinical Therapeutics, N.K.U.A

    NOT_YET_RECRUITING

    Athens, Attica, 115 28, Greece

  • General University Hospital Of Patras- Division of Oncology, Department of Medicine

    NOT_YET_RECRUITING

    Pátrai, 265 04, Greece

  • Grupo Medico ASSET S.C

    NOT_YET_RECRUITING

    Benito Juárez, 03100, Mexico

  • HagaZiekenhuis - Oncologie Interne Geneeskunde

    NOT_YET_RECRUITING

    The Hague, 2545 AA, Netherlands

  • Harbin Medical University Cancer Hospital

    NOT_YET_RECRUITING

    Harbin, Heilongjiang, 150000, China

  • Hong Kong United Oncology Centre

    NOT_YET_RECRUITING

    Kowloon, Kowloon, 00000, Hong Kong

  • Hospital Araujo Jorge Associaçao de Combate ao Cancer em Goias

    NOT_YET_RECRUITING

    Goiânia, Goiás, 74605-070, Brazil

  • Hospital Clinico Universitario De Valencia | Oncologia

    NOT_YET_RECRUITING

    Valencia, Valencia, 46010, Spain

  • Hospital Evangélico de Cachoeiro de Itapemirim

    NOT_YET_RECRUITING

    Vitória, Espírito Santo, 29047-660, Brazil

  • Hospital Italiano de Buenos Aires

    NOT_YET_RECRUITING

    Buenos Aires, Buenos Aires, C1199ABB, Argentina

  • Hospital Sirio Libanes - Oncology_Sao Paulo

    NOT_YET_RECRUITING

    São Paulo, São Paulo, 01308-050, Brazil

  • Hospital Umum Sarawak (Sarawak General Hospital) SGH

    NOT_YET_RECRUITING

    Kuching, Sarawak, 93586, Malaysia

  • Hospital Universitari Vall D Hebron | Oncologia

    NOT_YET_RECRUITING

    Barcelona, Barcelona, 08035, Spain

  • Hospital Universitario Ramon Y Cajal | Oncologia Medica

    NOT_YET_RECRUITING

    Madrid, Madrid, 28034, Spain

  • Hospital Universitario Virgen De La Victoria | Oncologia Medica

    NOT_YET_RECRUITING

    Málaga, Málaga, 20910, Spain

  • Hospital Universitrio Dr. José Eleuterio González. Servicio de Oncologia

    NOT_YET_RECRUITING

    Monterrey, 64460, Mexico

  • Hospital Wanita Dan Kanak Kanak Sabah - Oncology and Radiotherapy

    NOT_YET_RECRUITING

    Kota Kinabalu, Sabah, 88996, Malaysia

  • Hospital Zambrano Hellion

    NOT_YET_RECRUITING

    Monterrey, Nuevo León, 66278, Mexico

  • Hospital del Mar | Oncologia

    NOT_YET_RECRUITING

    Barcelona, 08003, Spain

  • Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia

    NOT_YET_RECRUITING

    Rozzano, 20089, Italy

  • Institut Jules Bordet - Clinique D'Oncology

    NOT_YET_RECRUITING

    Brussels, Brussels Capital, 1070, Belgium

  • Instituto Alexander Fleming

    NOT_YET_RECRUITING

    Buenos Aires, Buenos Aires, C1426ANZ, Argentina

  • Instituto Nacional de Cancerología

    NOT_YET_RECRUITING

    Mexico City, Mexico City, 14080, Mexico

  • Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E. - Serviço de Oncologia Médica

    NOT_YET_RECRUITING

    Lisbon, 1099-023, Portugal

  • Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. - Serviço de Oncologia Médica

    NOT_YET_RECRUITING

    Porto, 4200-072, Portugal

  • Instituto do Cancer do Estado de Sao Paulo

    NOT_YET_RECRUITING

    São Paulo, São Paulo, 01246-000, Brazil

  • Investigaciones Oncológicas C Colón

    NOT_YET_RECRUITING

    Mar Del Plata, Buenos Aires,, 7600, Argentina

  • Istituto Europeo di Oncologia s.r.l - Sviluppo di nuovi farmaci per Terapie Innovative

    NOT_YET_RECRUITING

    Milan, 20141, Italy

  • Kartal Dr Lutfi Kirdar Sehir Hastanesi- Medical Oncology

    NOT_YET_RECRUITING

    Istanbul, 34865, Turkey (Türkiye)

  • Keelung Chang Gung Memorial Hospital - Division of Hematology and Oncology

    NOT_YET_RECRUITING

    Keelung, 204201, Taiwan

  • Klinikum Oldenburg - Klinik für Onkologie und Hämatologie

    NOT_YET_RECRUITING

    Oldenburg, Lower Saxony, 26133, Germany

  • Krankenhaus Nordwest GmbH - Institut Fuer Klinisch-Onkologische Forschung (IKF)

    NOT_YET_RECRUITING

    Frankfurt am Main, Hesse, 60488, Germany

  • Laiko General Hospital Of Athens- Oncology Department

    NOT_YET_RECRUITING

    Athens, 11526, Greece

  • Leopoldina-Krankenhaus der Stadt Schweinfurt GmbH-Medizinische Klinik 2

    NOT_YET_RECRUITING

    Schweinfurt, Bavaria, 97422, Germany

  • Mary Babb Randolph Cancer Center

    NOT_YET_RECRUITING

    Morgantown, West Virginia, 26505, United States

  • Mazowiecki Szpital Wojewódzki Siedleckie Centrum Onkologii Oddział Onkologii Klinicznej i Radioterapii

    NOT_YET_RECRUITING

    Siedlce, 08-110, Poland

  • Metropolitan General Hospital -Oncologic Clinical Trials and Research Clinic

    NOT_YET_RECRUITING

    Cholargos/ Athens, 155 62, Greece

  • NAIC - Instituto do Cancer

    NOT_YET_RECRUITING

    Bauru, São Paulo, 17033-490, Brazil

  • Narodowy Instytut Onkologii im. Marii Skłodowskiej Curie Państwowy Instytut Badawczy- Oddział Warszawa Wawelska

    NOT_YET_RECRUITING

    Warsaw, 02-034, Poland

  • National Cancer Center Singapore - Oncology Department

    RECRUITING

    Singapore, 168583, Singapore

  • National Cheng Kung University Hospital

    NOT_YET_RECRUITING

    Tainan, Tainan, 704, Taiwan

  • National University Cancer Institute (NCIS)

    NOT_YET_RECRUITING

    Singapore, 119074, Singapore

  • Nucleo de Ensino e Pesquisa do Hospital de Clinicas de Ijuí

    NOT_YET_RECRUITING

    Ijuí, Rio Grande do Sul, 98700-000, Brazil

  • Oncare Viaducto Nápoles

    NOT_YET_RECRUITING

    Mexico City, 3810, Mexico

  • OncoCare Cancer Centre | Gleneagles Medical Centre

    NOT_YET_RECRUITING

    Singapore, 258499, Singapore

  • Opolskie Centrum Onkologii

    NOT_YET_RECRUITING

    Opole, 45-061, Poland

  • Pratia McM Kraków

    NOT_YET_RECRUITING

    Krakow, 30-727, Poland

  • Pratia Wroclaw

    NOT_YET_RECRUITING

    Wroclaw, 50-417, Poland

  • Prince of Wales Hospital

    NOT_YET_RECRUITING

    Shatin, New Territories, 00000, Hong Kong

  • Queen Mary Hospital

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong SAR, 00000, Hong Kong

  • Renati Innovation SAPI de CV

    NOT_YET_RECRUITING

    Guadalajara, 44680, Mexico

  • START Research Portugal - ULSS Maria - Unidade de Ensaios de Fase I Start Lisbon

    NOT_YET_RECRUITING

    Lisbon, 1649-035, Portugal

  • Saint Savvas Oncology Hospital -1st Internal Medicine - Oncology Department

    NOT_YET_RECRUITING

    Athens, Attica, 115 22, Greece

  • Samsung Medical Center | Oncology

    NOT_YET_RECRUITING

    Seoul, Seoul, 06351, South Korea

  • Sanatorio Allende | Departamento de Investigación Clínica

    NOT_YET_RECRUITING

    Córdoba, Córdoba Province, X5000JHQ, Argentina

  • Sanatorio Parque - Oncology

    NOT_YET_RECRUITING

    Rosario, Santa Fe Province, S2000GAP, Argentina

  • Seoul National University Bundang Hospital | Oncology

    NOT_YET_RECRUITING

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Seoul National University Hospital | Oncology

    NOT_YET_RECRUITING

    Jongno -Gu, Seoul, 03080, South Korea

  • Severance Hospital | Oncology

    NOT_YET_RECRUITING

    Seoul, Seoul, 03722, South Korea

  • Shandong University - Shandong Cancer Hospital

    NOT_YET_RECRUITING

    Jinan, Shandong, 250117, China

  • Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310016, China

  • Sunway Medical Centre - Medical Oncology

    NOT_YET_RECRUITING

    Subang Jaya, Selangor, 47500, Malaysia

  • Sunway Medical Centre Penang - Department of Clinical Oncology

    NOT_YET_RECRUITING

    Perai, Pulau Pinang, 13700, Malaysia

  • Taichung Veterans General Hospital | Division of Colorectal Surgery

    NOT_YET_RECRUITING

    Taichung, 407219, Taiwan

  • Taipei Veterans General Hospital

    NOT_YET_RECRUITING

    Taipei, Taipei, 11217, Taiwan

  • The First Affiliated Hospital of Bengbu Medical College

    NOT_YET_RECRUITING

    Bengbu, Anhui, 233004, China

  • The Sixth Affiliated Hospital, Sun Yat-sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510655, China

  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

    NOT_YET_RECRUITING

    Wuhan, Hubei, 430030, China

  • Trakya Univ. Tip Fak.

    NOT_YET_RECRUITING

    Edirne, 22030, Turkey (Türkiye)

  • UZ Gent - Digestive Oncology

    NOT_YET_RECRUITING

    Ghent, 9000, Belgium

  • UZ Leuven - Digestive oncology

    NOT_YET_RECRUITING

    Leuven, Flemish Brabant, 3000, Belgium

  • Unicancer Dijon - Centre Georges Francois Leclerc - Oncologie medicale

    NOT_YET_RECRUITING

    Dijon, 21000, France

  • Unicancer Marseille - Institut Paoli-Calmettes - Oncologie medicale

    NOT_YET_RECRUITING

    Marseille, 13009, France

  • Unidade Local de Saúde de Coimbra, E.P.E. - Hospitais da Universidade de Coimbra - Serviço de Oncologia

    NOT_YET_RECRUITING

    Coimbra, 3004-561, Portugal

  • Unidade Local de Saúde de São José, E.P.E - Hospital de Santo António dos Capuchos - Serviço de Oncologia Médica

    NOT_YET_RECRUITING

    Lisbon, 1169-050, Portugal

  • Unidade de Pesquisas Clinicas em Oncologia

    NOT_YET_RECRUITING

    Pelotas, Rio Grande do Sul, 96020-080, Brazil

  • Universitaetsklinikum Essen - Innere Klinik (Tumorforschung)

    NOT_YET_RECRUITING

    Essen, North Rhine-Westphalia, 45147, Germany

  • Universiti Malaya Medical Centre - Clinical Oncology Department

    NOT_YET_RECRUITING

    Kuala Lumpur, 59100, Malaysia

  • University College Hospital | Cancer Clinical Trials Unit

    NOT_YET_RECRUITING

    London, Greater London, NW1 2PG, United Kingdom

  • University Hospital Coventry | Oncology

    NOT_YET_RECRUITING

    Coventry, West Midlands, CV22DX, United Kingdom

  • University of Arizona Cancer Center - North Campus

    NOT_YET_RECRUITING

    Tucson, Arizona, 85719, United States

  • University of Michigan Rogel Cancer Center

    NOT_YET_RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie

    WITHDRAWN

    Zurich, Canton of Zurich, 8091, Switzerland

  • Universitätsklinikum Ulm - Klinik für Innere Medizin I

    NOT_YET_RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

  • VM Medical Park Samsun Hospital Medical Oncology Department

    NOT_YET_RECRUITING

    Samsun, 55200, Turkey (Türkiye)

  • West China Hospital Sichuan University

    NOT_YET_RECRUITING

    Chengdu, Sichuan, 610041, China

  • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu Oddział Onkologiczny z Pododdziałem Dziennej Chemioterapii

    NOT_YET_RECRUITING

    Przemyśl, 37-700, Poland

  • Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi

    NOT_YET_RECRUITING

    Lodz, 93-513, Poland

  • Yunnan Cancer Hospital

    NOT_YET_RECRUITING

    Kunming, Yunnan, 650118, China

  • Zhejiang Cancer Hospital

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310022, China

  • Zhongshan Hospital, Fudan University

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

  • İstanbul Medeniyet Üniversitesi Göztepe Süleyman Yalçın Şehir Hastanesi

    NOT_YET_RECRUITING

    Kadıköy, Istanbul, 34722, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.